MedTrace Logo

European Registry on STEMI Patients Transferred for PCI With Upstream Use of Abciximab - EuroTransfer Registry

NCT00378391 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2007-06-20

No results posted yet for this study

Summary

EUROTRANSFER Registry is a prospective, international, web-based European Registry on Patients with ST-Elevation MI Transferred for Mechanical Reperfusion (PCI) with a Special Focus on Upstream Use of Abciximab.

This registry is designed to collect data on approximately 1800 patients during a 12 month enrollment period in up to 20 interventional cardiology centres with hospital transfer networks from all over Europe.

Analysis of this registry should allow to monitor transfer timelines of patients arriving to the cath-lab from the regional hospital with or without upstream start of abciximab and scheduled for mechanical reperfusion (PCI) as well as to monitor regional differences across Europe in regard to the impact that time of various stages of the treatment chain may have on clinical outcomes.

Conditions

  • ST-Elevation Myocardial Infarction
  • Acute Coronary Syndrome

Sponsors & Collaborators

  • Foundation for Medical Research in Krakow, Poland

    collaborator UNKNOWN

  • Jagiellonian University

    lead OTHER

Principal Investigators

  • Dariusz Dudek, Assoc. Prof. · Cardiac Catheterization Laboratories, Jagiellonian University Medical College

  • Zbigniew Siudak, MD · Cardiac Catheterization Laboratories, Jagiellonian University Medical College

  • Lukasz Partyka, MD, PhD · KCRI

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Completion
2007-02-28

Countries

  • Finland
  • Germany
  • Italy
  • Poland
  • Slovenia
  • Spain
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00378391 on ClinicalTrials.gov